首页> 外文期刊>Annals of Coloproctology >Prognostic Impact of Immunonutritional Status Changes During Preoperative Chemoradiation in Patients With Rectal Cancer
【24h】

Prognostic Impact of Immunonutritional Status Changes During Preoperative Chemoradiation in Patients With Rectal Cancer

机译:直肠癌患者术前放化疗过程中免疫状态变化对预后的影响

获取原文
           

摘要

Purpose Previous studies have demonstrated the prognostic impact of the prognostic nutritional index (PNI), a proposed indicator of immunonutritional statuses of surgical patients, on patients with various gastrointestinal cancers. Although the prognostic impact of the PNI on patients with colorectal cancer has been well established, its value has not been studied in patients treated with preoperative chemoradiation (pCRT). This study aimed to evaluate the prognostic impact of PNI on patients receiving pCRT for locally advanced rectal cancer (LARC). Methods Patients with LARC who underwent curative pCRT followed by surgical resection were enrolled. The PNI was measured in all patients before and after pCRT, and the difference in values was calculated as the PNI difference (dPNI). Patients were classified according to dPNI (10). Clinicopathologic parameters and long-term oncologic outcomes were assessed according to dPNI classification. Results No significant intergroup differences were observed in clinicopathologic parameters such as age, histologic grade, tumor location, tumor-node-metastasis stage, and postoperative complications. Approximately 53% of the patients had a mild dPNI (10). Univariate and multivariate analyses identified the dPNI as an independent prognostic factor for disease-free status (P Conclusion The dPNI is predictive of long-term outcomes in pCRT-treated patients with LARC. Further prospective studies should investigate whether immune-nutritional status correction during pCRT would improve oncologic outcomes.
机译:目的先前的研究已经证明了预后营养指数(PNI)对各种胃肠道癌症患者的预后影响,PNI是外科手术患者免疫营养状况的拟议指标。尽管PNI对结直肠癌患者的预后影响已得到很好的确定,但尚未对术前化学放射(pCRT)治疗的患者研究其价值。这项研究旨在评估PNI对接受pCRT治疗的局部晚期直肠癌(LARC)患者的预后影响。方法招募行根治性pCRT并手术切除的LARC患者。在pCRT之前和之后对所有患者进行PNI测量,并将值差异计算为PNI差异(dPNI)。根据dPNI对患者进行分类(10)。根据dPNI分类评估临床病理参数和长期肿瘤学结局。结果在临床病理参数如年龄,组织学分级,肿瘤位置,肿瘤淋巴结转移阶段和术后并发症方面,未观察到明显的组间差异。大约53%的患者患有轻度dPNI(10)。单因素和多因素分析确定dPNI是无病状态的独立预后因素(P结论dPNI可以预测pCRT治疗的LARC患者的长期预后。进一步的前瞻性研究应调查pCRT期间是否进行免疫营养状况纠正将改善肿瘤学结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号